---
created: 2025-04-13
updated: 2025-04-13T10:53
id: s3+6:-!_yn
specialty: pharmaco
specialty_id: 554
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::04-cancer-drugs::01-antimetabolites
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::12-antimetabolites
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::12-antimetabolites::pyrimidine-synthesis-inhibitors::methotrexate
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::01-antimetabolites::01-methotrexate,-leucovorin,-5-fluorouracil,-hydroxyurea::zanki-extra
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1857
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^expn::bgnonessentials
  - source/ak-step1-v11::^other::^expn::uworld
  - source/ak-step1-v11::^other::^highyield::4-loweryield"
type: flashcard
---

# Question
Once methotrexate enters the targeted cell, it undergoes **polyglutamation**, preventing the movement of MTX out of the cell

---

# Answer
Similarly, folate and recycled DHF are stored within the cell via polyglutamation == dihydrofolate polyglutamate or DHF buildup